George R Jackson

George R Jackson, M.D., Ph.D., is a Professor of Neurology at Baylor College of Medicine and holds multiple clinical and research leadership roles, including Associate Director of Research at the Parkinson's Disease Research, Education and Clinical Center (PADRECC) at the Michael E. DeBakey Veterans Affairs Medical Center and Director of the Cognitive Disorders Clinic. He is also a member of the Center for Alzheimer's and Neurodegenerative Diseases.

Education:

• MD and PhD from University of Texas Medical Branch at Galveston
• Internship and Residency in Internal Medicine and Neurology at UCLA
• Neurogenetics Clinical Fellowship at UCLA
• Movement Disorders training at University of Texas Austin
• BS from University of Texas Austin

Research Interests: His work focuses on neurodegenerative diseases, particularly Alzheimer's and Parkinson's, with an emphasis on understanding disease pathogenesis, therapy development, and increasing underrepresented groups' participation in research. Key areas include movement disorders, dementias, and translational studies using Drosophila models. He explores interactions between amyloid-beta, tau proteins, and iron metabolism in neurodegeneration.

Key Contributions: Dr. Jackson’s research bridges clinical practice and scientific inquiry, particularly in veterans’ health. His studies investigate olfactory dysfunction in mild TBI survivors, therapeutic efficacy in essential tremor, and autophagy mechanisms in tauopathies. He collaborates with interdisciplinary teams to advance diagnostic tools and treatment strategies.

Awards: No awards explicitly listed in provided texts.

Advising & Grants: While specific grants or trainees aren’t detailed, his roles suggest involvement in VA and institutional grants. He leads clinical trials and translational studies, likely mentoring junior researchers through his clinical and research programs.

Labs & Teams: He contributes to the Center for Alzheimer's and Neurodegenerative Diseases at Baylor and collaborates with the PADRECC to advance clinical care and research for veterans with neurodegenerative conditions.